Research & Development: Page 36

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Welcome to 2017 From funding to policy changes, 2017 according to analysts will be marked by uncertainty and opportunity. As the industy, as well as the country, prepares for the Trump Administration, EY U.S. Analyst Arda Ural, Ph.D., details the impact the new president’s policies will have on d...

    By Taren Grom • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Way to Treat Severe Asthma Dr. Bing Yao, Respiratory, Inflammation & Autoimmunity Head at MedImmune, talks about the company’s efforts to develop a next-generation asthma therapy. Severe, uncontrolled asthma is a debilitating and potentially fatal form of the disease. Uncontrolled asthm...

    By Dr. Bing Yao • Jan. 1, 2017
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    AI and mHealth Tech: Instruments to Better Healthcare Computers can be trained to be more accurate than pathologists in assessing slides of lung cancer tissues, according to a study by researchers at the Stanford University School of Medicine. The researchers found that a machine-learning approac...

    By PharmaVoice Team • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Rising Pharma Opportunities in China Rick Pauls, President and CEO of DiaMedica, talks about how the Chinese market is poised for growth. PV: Why do you think the Chinese market has potential for the pharmaceutical industry? Pauls: The westernization of China is leading to increases in many disea...

    By Rick Pauls • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Venture Capital Funding

    According  to the MoneyTree Report from PwC, the life-sciences industry continues to be the second most invested destination after software, in terms of dollars. Life-Sciences’ VC Investment The life-sciences’ record-high investment spree of 2015 came to an end in Q4 with the lowest quarter of in...

    By PharmaVoice Team • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Organs On Chips

    One day, precision medicine will take into account the genes, environment, and lifestyle of each person. Through the use of an emerging technology that melds engineering, biology, and IT, researchers are able to see what hasn’t been possible before: the inner workings of human biology and disease...

    By Denise Myshko • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Disease State: HIV Update

    Since the beginning of the HIV epidemic, almost 70 million people worldwide have been infected with the virus that causes AIDS. It is estimated that 36.7 million people are currently living with HIV globally. Tremendous gains have been made in treating these patients, helping them to live longer,...

    By Denise Myshko • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Focus on Rare Diseases

    Rare diseases have been a focus of drug development for decades, and since the 1980s, there have been financial, legal, and legislative incentives, such as the Orphan Drug Act, that are drawing companies of all sizes to enter the market. Rafal Kokolus, senior engagement manager, inVentiv Health C...

    By PharmaVoice Team • Jan. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    CROs are Leading Drive to Improve the Efficiency of Clinical Trials  Trending now:  Survey reveals significant improvements in inspection readiness among CROs. A  global industry survey by Veeva of trial master file (TMF) owners shows growing use of electronic trial master file (eTMF) solutions a...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    Deloitte Launches ExaLink, a Multi-Services Platform for Commercial Operations Trending now:  New platform helps pharma companies transcend legacy enterprise systems. Deloitte has released a hybrid cloud-based, multi-services platform, ExaLink, to help life-sciences companies transform their comm...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trending 2017: Combination Products

    Combination products are products that combine two or more different types of FDA-regulated products, including drugs, biologics, and medical devices. Regulators are working to make this process easier with the establishment of the Combination Product Council, identifying process improvements, an...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trending 2017: Industrial Internet

    The Industrial Internet, a term coined by GE, is the integration of complex physical machinery with networked sensors and software. The next state of the Industrial Internet will enable artificial intelligence to make meaningful use of device-collected data. This near future state is generating e...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trending 2017: Smart Technology

    The ability to capture health information in real time is changing the face of healthcare and clinical trials. Take for example Novartis and Qualcomm’s next-generation inhaler that enables patients to have access to their own data on the use of their inhaler in near real time. The small, disposab...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trending 2017: Talent War

    For most organizations the war for talent isn’t just with their competitors; it’s a battle being waged on a global basis that transcends industries. As global megatrends escalate, companies are reshaping their businesses and innovating to meet new market demands. The challenge is talent innovatio...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Data-driven Site Selection Accelerating Your Trials Through Predictive Site Modeling

    Accelerated study start-up is the universally acknowledged holy grail of streamlining clinical trial operations. While advancements like central IRB review, adaptive trial designs, and the implementation of electronic systems have led to increased efficiencies across the clinical trial enterprise...

    By Suzanne Caruso • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out

    Changing the Drug Development Playbook –MODEL-INFORMED DRUG DEVELOPMENT HAS ARRIVED Imagine that you can reduce the number of patients required for a complex, hard-torecruit clinical trial by ten-fold. Imagine that you can use technology alone to add dosing information for special populations – s...

    By PharmaVoice Team • Nov. 21, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Clinical Data in Real Time The number of clinical trials using mobile apps more than doubled, rising from 135 in 2014 to 300 in 2015, according to the IMS Health Study Patient Options Expand as Mobile Healthcare Apps Address Wellness and Chronic Disease Treatment Needs. No doubt when 2016 numbers...

    By Taren Grom • Oct. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Industry at Large BMS Employees Cycle Coast to Coast to Raise Money for Cancer Research The first of six teams of Bristol-Myers Squibb oncology employees set out in September from Cannon Beach on the Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer Ride, a 21-day cycling ride that...

    By PharmaVoice Team • Oct. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Era for “Bubble Boy" Disease Sven Kili, M.D., head of gene therapy development at GlaxoSmithKline, talks about the company’s gene therapy to treat a very rare immune system disorder, which recently received EU approval. Children born with a specific immune disorder — severe combined immunod...

    By Sven Kili • Oct. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Calendar

    Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting." The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build the...

    By PharmaVoice Team • Oct. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The Future of Research All the innovation that is happening in research labs around the globe may come to naught if the sites, patients, and physician investigators needed to move the science forward are not a substantive part of the equation. In this month’s cover story “Why Sites Matter," the c...

    By Taren Grom • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Industry at Large MMRF, Takeda, and CURE Media Join Forces to Support Hiking Team A team of 20 multiple myeloma patients, caregivers, physicians, nurses, and supporters hiked along Peru’s arduous Inca Trail leading to the ruins of Machu Picchu to raise funds for research and to build awareness ar...

    By PharmaVoice Team • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    mHealth

    Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now:  Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...

    By PharmaVoice Team • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Following the Science Bill Hinshaw, Executive VP and Head of Novartis Oncology US, talks about the company’s efforts to create innovation in the cancer arena. PV: What is Novartis doing to encourage innovation? Hinshaw: Transforming cancer care is a core part of our mission. Novartis as a corpora...

    By Bill Hinshaw • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Why Sites Matter

    Clinical sites face several challenges, including predictability of trial business, payments, and technology issues, in addition to a highly fragmented clinical trial landscape. Many of the challenges that sites face reflect the changing landscape of clinical research. Sites are responsible for m...

    By Denise Myshko • Sept. 1, 2016